Unbound MEDLINE

Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K [Leukemia] Journal article

 
TitleCoding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study.
Author(s)Lamba JK, Pounds S, Cao X, Downing JR, Campana D, Ribeiro RC, Pui CH, Rubnitz JE 
Institution1Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN, USA.
SourceLeukemia 2008 Jul 10.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID18615103
  
Advertise on this site.